Ineffective Airway Clearance ANATOMY OF THE RESPIRATORY TRACT Structures and Functions of Respiratory System Physiology of Respiration Arterial blood gases Mixed venous blood gases Oximetry Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Assessment of Respiratory System Auscultation Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Assessment of Respiratory System Abnormal breath sounds Adventitious sounds Fine crackles Coarse crackles Rhonchi Wheezes Stridor Pleural friction rub Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Arterial Blood Gas Elements ABG Element Normal Value Range pH 7.4 7.35 to 7.45 Pa02 90mmHg 80 to 100 mmHg Sa02 93 to 100% PaC02 40mmHg 35 to 45 mmHg HC03 24mEq/L 22 to 26mEq/L UPPER AIRWAY OBSTRUCTION As evidenced by Increased respiratory rate > 24/min Change in respiratory character ↓depth – shallow Snore-like or noisy Change in breath sounds Limited or no air movement Stridor-high pitched C/O “cannot breathe,” SOB, chest pain ↓ SpO2 http://www.youtube.com/watc ↑ Pulse, ↑ BP h?v=QkaX83H31QY&playne xt=1&list=PLBC00F19576AB ↓ LOC, ↑ restlessness 0D74&index=3 GENERAL NURSING INTERVENTIONS Positioning Open airway, ↑ HOB Oxygen/AMBU Remove foreign body Suctioning/Manual removal Decrease Edema Meds- steroids Ice packs to nasal area THE PATIENT WITH A TRACHEOSTOMY NURSING MANAGEMENT Tracheostomy The stoma that results from the tracheotomy Indications Bypass upper airway Facilitate removal of secretions Long term ventilation Permits oral intake and speech who require long-term mechanical ventilation ADVANTAGES OF A TRACHEOSTOMY Less risk of long-term damage to airway Increased comfort Patient can eat Increased mobility because tube is more secure TRACHEOSTOMY TUBE NURSING MANAGEMENT: TRACH CARE • • • • Suctioning Site Care: cleaning stoma, changing dressing and ties Inner cannula care Bedside equipment • • • • • Obturator replacement trach tube suction equipment Oxygen AMBU bag TRACH MANAGEMENT Why • • Inflate cuff risk of aspiration mechanical ventilation Inflate with minimum volume to create an airway seal Pressure should not exceed 20 mm Hg or 25 cm H2 O CARE OF THE PATIENT WITH A TRACHEOSTOMY Nursing Diagnosis Ineffective Airway Clearance Risk for Infection Impaired Verbal Communication Impaired Swallowing Nursing Management: Lower Respiratory Problems Pneumonia Pneumonia An excess of fluid in the lungs caused by an inflammatory process Possible causes: Microorganisms (bacterial, viral, or fungal) Aspiration Chemical irritants Leading disease cause of death due to infectious Hospital-acquired pneumonia Occurring 48 hrs or longer after admission Second most common nosocomial infection • Risk factors Immunosuppressive General therapy debility Endotracheal intubation Community-acquired Pneumonia Lower respiratory infection of lung Onset in community or during first 2 days of hospitalization 4 million U.S. adults diagnosed yearly Highest incidence in midwinter Smoking important risk factor Community Acquired Pneumonia Clinical Manifestations Symptoms Sudden onset of fever Chills Cough productive of purulent, bloodtinged, or rustcolored sputum Pleuritic chest pain Atypical symptoms Gradual onset Dry cough Extrapulmonary manifestations, nausea, vomiting, and diarrhea Physical Examination Findings Dyspnea Tachypnea Dullness to percussion Fremitus Bronchial breath sounds Crackles Tachycardia Flushing Cyanosis Confusion Delirium Diagnostic Tests Pulse History Physical examination Chest x-ray Gram stain of sputum Sputum culture and sensitivity oximetry or ABGs CBC, differential, chemistries Blood cultures Treatment Based on Known risk factors Severity of illness Suspected or identified organism Antibiotic 10-14 days Empiric Pathogen specific Medications Antibiotic therapy Respiratory Fluroquinolone Antivirals Aymanadine, Flumadine Mucolytics/expectorants Mucinex Antipyretics Anti-tussive Robituusin, Tessalon pearls Analgesics morphine, codeine, Dilaudid Collaborative Care Oxygen for hypoxemia Influenza drugs and influenza vaccine Fluid intake at least 3 L per day Small frequent meals Prevent aspiration Position change Q 2 hours Collaborative Care Pneumococcal vaccine at risk Chronic illness such as heart and lung disease, diabetes mellitus Recovering from severe illness 65 or older Long-term care facility resident Nursing Diagnoses Impaired gas exchange Ineffective breathing pattern Acute pain Hyperthermia Imbalanced nutrition: Less than body requirements Activity intolerance Goals Clear breath sounds Normal breathing patterns No signs of hypoxia Normal chest x-ray No complications related to pneumonia Evaluation Dyspnea not present SpO2 ≥ 95 Free of adventitious breath sounds Clears sputum from airway Reports pain control Verbalizes causal factors Adequate fluid and caloric intake Perform activities of daily living Pulmonary Tuberculosis Nursing Management What is Tuberculosis An infectious disease caused by Mycobacterium tuberculosis Spreads through airborne droplets May also occur in the kidneys, bones, adrenal glands, lymph nodes, and meninges and can be disseminated throughout the body Who is at Risk? Crowded, poverty stricken settings Homeless persons Elderly Healthcare workers and others such as prison guards Residents of long term care facilities Alcoholics and IV drug users Low socioeconomic background and medically underserved Clinical Findings Early stages usually symptom free incidental Systemic fatigue, findings with routine CXRs symptoms malaise, anorexia/weight loss, low-grade fevers (esp. in the late afternoon), and night sweats Cough that becomes frequent and produces mucopurulent sputum May have dull or tight chest pain Lab & Diagnostic Findings Sputum To Culture examine for acid-fast bacilli (AFB) Cultures positive for M.Tuberculosis confirm the diagnosis of TB Perform q 2-4wks to determine effectiveness of medication therapy CXR Lab & Diagnostic Findings TB skin test Positive reaction occurs 3-10 wks after the initial infection Once acquired, test always positive Does not show whether the infection is dormant or active For the immunocompromised, smaller indurations may be considered positive Determines presence of active or calcified lesions Drug Therapy Regimen For TB: Latent TB Infection Treatment Regimens Isoniazid (INH) for 9 months (standard) Daily or *twice/week INH for 6 months Daily or *twice/week INH and Rifapentine for 3 months *Once weekly Rifampin (RI) for 4 months Daily * Directly Observe Therapy Nursing Management: Drug Therapy Patient After considered noninfectious 2-3 weeks of continuous medication therapy Three negative sputum (AFB) smears Nursing Management: Medication side effects Major side effect of medications is hepatitis Rifampin: educate patient that urine, feces, sputum, tears, and sweat will have red-orange discoloration Isoniazid: peripheral neuropathy Streptomycin: damage to eighth cranial nerve Nursing Management Encourage liquids Small, frequent meals High-carbohydrate, high-protein, high-vitamin diet Vitamin B-6 supplementation Reduce elevated temp Improve gas exchange Provide client & family teaching and referrals Avoid smoking, asbestos, secondhand smoke Consult social services Acute Interventions Respiratory isolation Drug therapy Immediate workup (CXR, sputum smear, and culture) Teach client to cover nose & mouth with tissue when coughing and sneezing Teach good hand washing techniques Chest Trauma Thoracic Injuries Pneumothorax Air entering the pleural cavity Types Spontaneous-Rupture of small blebs Iatrogenic-Oops! Traumatic-Penetrating Tension-Pressure Hemothoax-Bleeding Chylothorax-Lymphatic fluid Treatment None Chest tube Water seal Nursing Care: Patient with Chest Tube Assessment of respiratory status Assessment of chest tube, drainage & system Is it patent? How much drainage? Correct suction? Any air leaks? Clamping What happens if it becomes disconnected? Patient Transportation Chest Tube Removal Chest Tube Removal--when lungs are re-expanded and fluid drainage has ceased Sutures Apply removed sterile petroleum jelly gauze dressing Patient takes a deep breath, exhaling, and Valsalva’s maneuver MD removes Apply dressing, observe for several days Pulmonary Embolism Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Pulmonary Embolism Blockage of pulmonary arteries by thrombus, fat or air embolus, or tumor tissue Obstructs alveolar perfusion Most commonly affects lower lobes Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 49 Pulmonary Embolism From: Brooks, M.L., Exploring Medical Language – A Student-Directed Approach, Mosby Elsevier, 2012 From: Brooks, M.L., Exploring Medical Language – A Student-Directed Approach, Mosby Elsevier, 2005 Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Risk Factors Deep vein thrombosis (90%) Immobility or reduced mobility Surgery History of DVT Malignancy Obesity Oral contraceptives/ hormones Smoking Heart failure Pregnancy/delivery Clotting disorders Atrial fibrillation Central venous catheters Fractured long bones Clinical Manifestations Variable Dyspnea most common Tachypnea, cough, chest pain, hemoptysis, crackles, wheezing, fever, tachycardia, syncope, change in LOC Dependent on size and extent of emboli Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Complications Pulmonary Alveolar necrosis and hemorrhage Abscess Pleural effusion Pulmonary infarction hypertension Results from hypoxemia associated with massive or recurrent emboli Right ventricular hypertrophy Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Diagnostic Studies Arterial blood gases Chest x-ray Electrocardiogram Troponin levels B-type natriuretic peptide Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Diagnostic Studies D-Dimer Elevated with any clot degradation False negatives with small PE Spiral (helical) CT scan Most frequently used dx test Requires IV contrast media Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Diagnostic Studies Ventilation-perfusion (V/Q) scan Used if patient cannot have contrast Two components Perfusion scanning Ventilation scanning Pulmonary angiography Most sensitive but invasive Arterial blood gases (ABGs) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. When admitting a 45-year-old female with a diagnosis of pulmonary embolism, the nurse will assess the patient for which risk factors (select all that apply)? A. Obesity Pneumonia C. Malignancy D. Cigarette smoking E. Prolonged air travel 20% 20% 20% 20% 20% on g ed ai rt ra ve l ng sm ok i et te ar M al ign Ci g Pr ol an cy a on i m Pn eu Ob es ity B. 30 Collaborative Care Prevention—the key! Sequential compression devices Early ambulation Prophylactic anticoagulation Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Collaborative Care Goals of treatment Prevent further thrombi Prevent further embolization to pulmonary system Provide cardiopulmonary support Supportive care variable Oxygen → mechanical ventilation Pulmonary toilet Fluids, diuretics, analgesics Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Drug Therapy Anticoagulation Low-molecular-weight heparin (LHWH) Unfractionated IV heparin Warfarin (Coumadin) Fibrinolytic agents Tissue plasminogen activator (tPA) Alteplase (Activase) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Surgical Therapy Pulmonary embolectomy for massive PE Inferior vena cava (IVC) filter Prevents migration of clots in pulmonary system Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Inferior Vena Cava Filters Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Nursing Management Semi-Fowler’s position IV access Oxygen therapy Frequent cardio/pulmonary assessments Monitor laboratory results. Emotional support and reassurance Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Patient Teaching Regarding long-term anticoagulant therapy Measures to prevent DVT Importance of follow-up exams Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Evaluation • Expected Outcomes Adequate tissue perfusion and respiratory function Adequate cardiac output Increased level of comfort No recurrence of PE Copyright © 2014 by Mosby, an imprint of Elsevier Inc. The nurse instructs a patient with a pulmonary embolism about administering enoxaparin (Lovenox) after discharge. Which statement by the patient indicates understanding about the instructions? ed ic i ne of ... sm air tt hi th e je c pe l “I w ill in ex ill w “I 0% ... 0% ou t ed m hi s et ta k to ne ed “I 0% i.. . v. .. di ss ol ill w ne ici D. 0% m ed C. he B. “The medicine will dissolve the clot in my lung.” “I need to take this medicine with meals.” “I will expel the air out of the syringe before I administer.” “I will inject this medicine into my abdomen.” “T A. 30